Back to

Dr James Pham

Conjoint Associate Lecturer

BMed/MD (UNSW)

Medicine & Health
School of Clinical Medicine

Since 2021, James has been a conjoint associate lecturer with the School of Clinical Medicine, UNSW Medicine and Health (St Vincent's Clinical Campus), conducting bedside tutorials, clinical skills sessions, mock exam trials and exam assessing for Phase 1 to 3 students. 

James is also himself actively engaged with academic research independently of his work as a junior medical officer, in the form of publications, conference posters and oral presentations, for the sake of furthering his development as an early career researcher with a passion for expanding the current state of medical knowledge to improve patient care. He has a special interest in the fields of dermatology, oncology, pharmacotherapy and immunology, and has actively sought to impart this onto his peers via Grand Rounds presentations and JMO teaching at St Vincent's Hospital.
E-mail
james.pham@unsw.edu.au
  • Journal articles | 2024
    Flora A; Jepsen R; Pham J; Frew JW, 2024, 'Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial', Journal of Investigative Dermatology, 144, pp. 786 - 793.e1, http://dx.doi.org/10.1016/j.jid.2023.10.005
    Journal articles | 2024
    Flora A; Jepsen R; Pham J; Frew JW, 2024, 'Rapid Attenuation of B-Cell and IFN-γ–Associated Chemokines in Clinical Responders to Jak Inhibition with Upadacitinib in Hidradenitis Suppurativa', Journal of Investigative Dermatology, 144, pp. 416 - 419.e5, http://dx.doi.org/10.1016/j.jid.2023.07.023
    Journal articles | 2024
    Flora A; Pham J; Jepsen R; Frew JW, 2024, 'The serum proteome of pyoderma gangrenosum is more expansive than that of hidradenitis suppurativa', Journal of the European Academy of Dermatology and Venereology, 38, pp. e348 - e350, http://dx.doi.org/10.1111/jdv.19611
    Journal articles | 2024
    Pham JP; Allen N; Star P; Cust AE; Stewart C; Guitera P; Marghoob AA; Smith A, 2024, 'Full-body skin examination in screening for cutaneous malignancy: a focus on concealed sites and the practices of Australian dermatologists', International Journal of Dermatology, 63, pp. 467 - 473, http://dx.doi.org/10.1111/ijd.16942
    Journal articles | 2024
    Pham JP; Jepsen R; Frew JW, 2024, 'Comment on Kridin et al.—Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis', Journal of the European Academy of Dermatology and Venereology, 38, pp. e351 - e353, http://dx.doi.org/10.1111/jdv.19615
    Journal articles | 2024
    Pham JP; Rodrigues A; Goldinger SM; Sim HW; Liu J, 2024, 'Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis', Experimental Dermatology, 33, http://dx.doi.org/10.1111/exd.14978
    Journal articles | 2023
    Pham JP; Boot M; Stefani M; Chapman S; Byrne A; Abdel-Shaheed C; Girgis L, 2023, 'Disseminated Mycobacterium chelonae infection complicating rheumatoid arthritis: A case report and review of the literature', International Journal of Rheumatic Diseases, 26, pp. 1167 - 1171, http://dx.doi.org/10.1111/1756-185X.14605
    Journal articles | 2023
    Pham JP; Frew JW, 2023, 'Reply to Tilotta and Bongiorno: Considering the role of resident cutaneous memory T-cell suppression in providing durable atopic dermatitis remission', Journal of the European Academy of Dermatology and Venereology, 37, pp. e1173 - e1174, http://dx.doi.org/10.1111/jdv.19179
    Journal articles | 2023
    Pham JP; Hillman RJ; Smith A, 2023, 'Re: ‘The impact of systemic psoriasis treatments on human papillomavirus activation and propagation’—What about anal malignancies?', Australasian Journal of Dermatology, 64, pp. e204 - e206, http://dx.doi.org/10.1111/ajd.14009
    Journal articles | 2023
    Pham JP; Joshua AM; da Silva IP; Dummer R; Goldinger SM, 2023, 'Chemotherapy in Cutaneous Melanoma: Is There Still a Role?', Current Oncology Reports, 25, pp. 609 - 621, http://dx.doi.org/10.1007/s11912-023-01385-6
    Journal articles | 2023
    Pham JP; On L; Ardolino L; Hurwitz J; Salaun H; Sim HW; Joshua AM, 2023, 'Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis', Melanoma Research, 33, pp. 316 - 325, http://dx.doi.org/10.1097/CMR.0000000000000900
    Journal articles | 2023
    Pham JP; Sivasubramaniam V; Gallagher R; Forstner D; Wong M; Liu J, 2023, 'Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis', Journal of the European Academy of Dermatology and Venereology, 37, pp. e363 - e365, http://dx.doi.org/10.1111/jdv.18649
    Journal articles | 2023
    Pham JP; Wark KJL; Woods J; Frew JW, 2023, 'Resident cutaneous memory T cells: a clinical review of their role in chronic inflammatory dermatoses and potential as therapeutic targets', British Journal of Dermatology, 189, pp. 656 - 663, http://dx.doi.org/10.1093/bjd/ljad303
    Journal articles | 2023
    Pham JP; Yang A; Frew JW, 2023, 'Academic dermatology in Australia and New Zealand between 2017 and 2022: A cross-sectional bibliometric analysis', Australasian Journal of Dermatology, 64, pp. 213 - 220, http://dx.doi.org/10.1111/ajd.14025
    Journal articles | 2022
    Pham JP; Aivazian K; Smith A, 2022, 'Acute generalised exanthematous pustulosis and cutaneous vasculitis: Not always just pustules?', Australasian Journal of Dermatology, 63, pp. 136 - 139, http://dx.doi.org/10.1111/ajd.13776
    Journal articles | 2022
    Pham JP; Allen N; Smith A, 2022, 'Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series', Australasian Journal of Dermatology, 63, pp. 522 - 524, http://dx.doi.org/10.1111/ajd.13925
    Journal articles | 2022
    Pham JP; Beale G; Gorji M; Thompson B; Al-Soufi S; Stone E, 2022, 'Severe disseminated primary varicella in a patient on long term inhaled corticosteroids', Respirology Case Reports, 10, http://dx.doi.org/10.1002/rcr2.1010
    Journal articles | 2022
    Pham JP; Star P; Ardolino L; Smith A; Joshua AM, 2022, 'A review of the cutaneous toxicities of tebentafusp—Featuring two cases involving superficial bullous reactions', Australasian Journal of Dermatology, 63, pp. e279 - e282, http://dx.doi.org/10.1111/ajd.13866
    Journal articles | 2022
    Pham JP; Star P; Phan K; Loh Y; Joshua AM; Smith A, 2022, 'BRAF inhibition and the spectrum of granulomatous reactions', Journal of the American Academy of Dermatology, 87, pp. 605 - 613, http://dx.doi.org/10.1016/j.jaad.2021.10.030
    Journal articles | 2022
    Pham JP; Star P; Smith A, 2022, 'Morbilliform eruption and systemic inflammatory response syndrome following mRNA COVID-19 vaccination in a patient receiving penicillamine', International Journal of Women's Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000058
    Journal articles | 2021
    Pham JP; Star P; Wong S; Damian DL; Saw RPM; Whitfeld MJ; Menzies AM; Joshua AM; Smith A, 2021, 'Cutaneous sarcoidosis due to immune-checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor', Skin Health and Disease, 1, http://dx.doi.org/10.1002/ski2.71
    Journal articles | 2021
    Raiker R; Pakhchanian H; Pham J; Phan K, 2021, 'Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis', Journal of Dermatology, 48, pp. 1619 - 1621, http://dx.doi.org/10.1111/1346-8138.16073
  • Conference Abstracts | 2022
    Pham J; Aivazian K; Smith A, 2022, 'If your ears are burning we must be talking about Red Ear Syndrome: A case report', in Australasian Journal of Dermatology, Wiley, Vol. 63, pp. e244 - e246, presented at Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.13862
    Conference Abstracts | 2022
    Pham J; Star P; Phan K; Loh Y; Joshua AM; Smith A, 2022, 'BRAF inhibition and the spectrum of Granulomatous Reactions', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 63, pp. 106 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000788396100260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Pham J; Star P; Smith A, 2022, 'Morbiliform eruption and Systemic Inflammatory Response Syndrome following COVID-19 mRNA vaccination', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 63, pp. 63 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000788396100159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2022
    Pham JP; Glasenhardt K; Garg A; Frew JW, 2022, 'Interpretation of comorbidity risk in hidradenitis suppurativa: comparing odds ratio and ‘number needed to be exposed’', in Journal of the European Academy of Dermatology and Venereology, pp. e1004 - e1006, http://dx.doi.org/10.1111/jdv.18403
    Conference Papers | 2022
    2022, 'Pathology/CPC', in Australasian Journal of Dermatology, Wiley, pp. 122 - 123, http://dx.doi.org/10.1111/ajd.14_13832